Published in Milbank Q on July 08, 2013
Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis (2014) 1.76
Barriers to HIV Care and Treatment Among Participants in a Public Health HIV Care Relinkage Program. AIDS Patient Care STDS (2015) 1.07
Addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States. J Acquir Immune Defic Syndr (2015) 1.06
Outcomes of a Clinic-Based Surveillance-Informed Intervention to Relink Patients to HIV Care. J Acquir Immune Defic Syndr (2015) 0.96
Using HIV surveillance registry data to re-link persons to care: the RSVP Project in San Francisco. PLoS One (2015) 0.96
Sorting through the lost and found: are patient perceptions of engagement in care consistent with standard continuum of care measures? J Acquir Immune Defic Syndr (2015) 0.89
Acceptance of the use of HIV surveillance data for care engagement: national and local community perspectives. J Acquir Immune Defic Syndr (2015) 0.87
Ethical aspects of malaria control and research. Malar J (2015) 0.80
HIV provider and patient perspectives on the Development of a Health Department "Data to Care" Program: a qualitative study. BMC Public Health (2016) 0.78
"Out of Care" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US. J Acquir Immune Defic Syndr (2017) 0.77
Re-engagement in HIV Care: A Clinical and Public Health Priority. J AIDS Clin Res (2016) 0.75
Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group. J Acquir Immune Defic Syndr (2017) 0.75
Improving Retention in HIV Care Through New York's Expanded Partner Services Data-to-Care Pilot. J Public Health Manag Pract (2016) 0.75
Criminalization of HIV Exposure: A Review of Empirical Studies in the United States. AIDS Behav (2016) 0.75
Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement Efforts. AIDS Patient Care STDS (2016) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. J Am Coll Dent (2014) 22.13
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (2000) 8.86
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis (2006) 7.42
The survival benefits of AIDS treatment in the United States. J Infect Dis (2006) 7.08
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep (2011) 6.90
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med (2007) 6.26
An ethics framework for public health. Am J Public Health (2001) 6.11
Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet (2012) 5.81
A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52
Public health ethics: mapping the terrain. J Law Med Ethics (2002) 5.29
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS (2004) 4.64
Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr (2006) 4.49
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis (2002) 4.43
Applying public health principles to the HIV epidemic. N Engl J Med (2005) 4.28
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS (2010) 3.44
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis (2009) 3.30
Projected life expectancy of people with HIV according to timing of diagnosis. AIDS (2012) 3.09
HIV System Navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS (2007) 3.02
Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population. Sex Transm Dis (2013) 2.92
Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr (2005) 2.75
Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system. Clin Infect Dis (2011) 2.57
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS (2010) 2.54
Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep (2008) 2.51
Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep (1995) 2.43
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS (2007) 2.39
Tracking diabetes: New York City's A1C Registry. Milbank Q (2009) 2.34
Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr (2010) 2.21
Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr (2012) 2.15
"Getting me back on track": the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS (2007) 2.09
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
Retention in care of persons newly diagnosed with HIV: outcomes of the Outreach Initiative. AIDS Patient Care STDS (2007) 1.81
Ethical collection, storage, and use of public health data: a proposal for a national privacy protection. JAMA (2009) 1.80
Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS (2012) 1.76
Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDS (2007) 1.55
Surveillance, social risk, and symbolism: framing the analysis for research and policy. J Acquir Immune Defic Syndr (2000) 1.54
The promise of outreach for engaging and retaining out-of-care persons in HIV medical care. AIDS Patient Care STDS (2007) 1.52
A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One (2012) 1.50
Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS One (2007) 1.47
Implementation of an innovative, integrated electronic medical record (EMR) and public health information exchange for HIV/AIDS. J Am Med Inform Assoc (2011) 1.47
Ethics in public health research: privacy and public health at risk: public health confidentiality in the digital age. Am J Public Health (2008) 1.34
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications. AIDS Patient Care STDS (2009) 1.27
Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007. AIDS (2012) 1.27
HIV surveillance, public health, and clinical medicine--will the walls come tumbling down? N Engl J Med (2011) 1.24
Most positive HIV western blot tests do not diagnose new cases in New York City: implications for HIV testing programs. J Acquir Immune Defic Syndr (2009) 1.22
Partner notification for HIV and syphilis: effects on sexual behaviors and relationship stability. Sex Transm Dis (2003) 1.20
Race, place and AIDS: the role of socioeconomic context on racial disparities in treatment and survival in San Francisco. Soc Sci Med (2009) 1.20
Public health ethics theory: review and path to convergence. J Law Med Ethics (2012) 1.19
Public goods, private data: HIV and the history, ethics, and uses of identifiable public health information. Public Health Rep (2007) 1.16
Delayed entry into HIV medical care after HIV diagnosis: risk factors and research methods. AIDS Care (2012) 1.11
Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care. Open AIDS J (2012) 1.08
Improved HIV-related outcomes associated with implementation of a novel public health information exchange. Int J Med Inform (2012) 1.07
Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retroviruses (2010) 1.07
Back to the future? Diabetes, HIV, and the boundaries of public health. J Health Polit Policy Law (2007) 1.03
Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression. HIV Med (2009) 1.01
Changes in partnerships and HIV risk behaviors after partner notification. Sex Transm Dis (2003) 0.94
HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDS (2011) 0.94
Letter to the Editor: Treatment as prevention: are HIV clinic patients interested in starting antiretroviral therapy to decrease HIV transmission? AIDS Patient Care STDS (2010) 0.93
The role of state law in protecting human subjects of public health research and practice. J Law Med Ethics (2003) 0.89
Informational privacy, public health, and state laws. Am J Public Health (2011) 0.88
Integration of HIV testing and linkage to care by the Baltimore City Health Department. Sex Transm Dis (2010) 0.87
Missed connections: HIV-infected people never in care. Public Health Rep (2013) 0.85
Trust, confidentiality, and the acceptability of sharing HIV-related patient data: lessons learned from a mixed methods study about Health Information Exchanges. Implement Sci (2012) 0.83
The legal and ethical fiction of "pure" confidentiality. Am J Bioeth (2006) 0.83
Linkages to care for newly diagnosed individuals who test HIV positive in nonprimary care settings. AIDS Patient Care STDS (2012) 0.80
Removing legal barriers to high-quality care for HIV-infected patients. N Engl J Med (2012) 0.76
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet (2006) 5.34
The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS (2009) 3.78
Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis (2006) 3.72
Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS (2010) 3.44
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int (2008) 2.49
Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr (2012) 2.47
Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr (2008) 2.36
Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis (2010) 2.34
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 2.29
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS (2008) 2.13
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS (2012) 1.88
Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis (2011) 1.83
Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort. J Acquir Immune Defic Syndr (2006) 1.77
Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr (2013) 1.73
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 1.72
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med (2009) 1.69
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr (2008) 1.68
Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry (2007) 1.68
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol (2009) 1.63
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study. J Int Assoc Physicians AIDS Care (Chic) (2007) 1.59
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting. Clin Infect Dis (2010) 1.51
Duration of highly active antiretroviral therapy regimens. Clin Infect Dis (2003) 1.50
A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One (2012) 1.50
Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS (2004) 1.45
Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS (2013) 1.43
A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis (2012) 1.42
Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure. J Acquir Immune Defic Syndr (2009) 1.41
Antiretroviral prescribing patterns in treatment-naïve patients in the United States. AIDS Patient Care STDS (2010) 1.40
Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Prefer Adherence (2011) 1.37
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South. South Med J (2007) 1.36
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr (2008) 1.36
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr (2012) 1.30
Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr (2012) 1.27
Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era. Clin Infect Dis (2007) 1.26
HIV transmission in a state prison system, 1988-2005. PLoS One (2009) 1.24
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr (2013) 1.23
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Health-related beliefs and decisions about accessing HIV medical care among HIV-infected persons who are not receiving care. AIDS Patient Care STDS (2009) 1.21
Standardizing laboratory data by mapping to LOINC. J Am Med Inform Assoc (2006) 1.19
Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS (2011) 1.19
Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDS (2008) 1.17
Coping with HIV stigma: do proactive coping and spiritual peace buffer the effect of stigma on depression? AIDS Behav (2012) 1.17
Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics (2011) 1.16
Short-term discontinuation of HAART regimens more common in vulnerable patient populations. AIDS Res Hum Retroviruses (2008) 1.15
Increased HIV and primary and secondary syphilis diagnoses among young men--United States, 2004-2008. J Acquir Immune Defic Syndr (2011) 1.14
Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic. Clin Infect Dis (2010) 1.14
HIV-related risk behaviors, perceptions of risk, HIV testing, and exposure to prevention messages and methods among urban American Indians and Alaska Natives. AIDS Educ Prev (2006) 1.14
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
HIV infection and obesity: where did all the wasting go? Antivir Ther (2012) 1.13
Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr (2006) 1.12
Homelessness and HIV-associated risk behavior among African American men who inject drugs and reside in the urban south of the United States. AIDS Behav (2007) 1.11
HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AIDS Patient Care STDS (2009) 1.11
The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load? Clin Infect Dis (2011) 1.10
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Using HIV surveillance data to monitor missed opportunities for linkage and engagement in HIV medical care. Open AIDS J (2012) 1.08
Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care (2011) 1.06
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis (2014) 1.06
Understanding people who have never received HIV medical care: a population-based approach. Public Health Rep (2010) 1.06
Patient reported outcomes in routine care: advancing data capture for HIV cohort research. Clin Infect Dis (2011) 1.04
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. J Acquir Immune Defic Syndr (2009) 1.04
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr (2010) 1.04
Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks. AIDS Res Hum Retroviruses (2010) 1.03
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. AIDS (2011) 1.03
Test-retest reliability of a complex human immunodeficiency virus research questionnaire administered by an Audio Computer-assisted Self-interviewing system. Med Care (2003) 1.02
Durability of initial antiretroviral therapy in a resource-constrained setting and the potential need for zidovudine weight-based dosing. J Acquir Immune Defic Syndr (2010) 1.02
Connecting race and place: a county-level analysis of White, Black, and Hispanic HIV prevalence, poverty, and level of urbanization. Am J Public Health (2014) 1.00
Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways. J Acquir Immune Defic Syndr (2012) 1.00
HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. Clin Infect Dis (2014) 1.00
Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study. AIDS Care (2011) 0.99
Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr (2012) 0.99
Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health (2003) 0.99
Systems for rapidly detecting and treating persons with ebola virus disease--United States. MMWR Morb Mortal Wkly Rep (2015) 0.99
HIV care at a crossroads: the emerging crisis in the US HIV epidemic. MedGenMed (2007) 0.99
Characteristics of an ambulatory palliative care clinic for HIV-infected patients. J Palliat Med (2013) 0.98
Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients. Clin Infect Dis (2010) 0.98
Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patients. Prev Chronic Dis (2013) 0.98
Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clin Infect Dis (2012) 0.98
The influence of perceptions of HIV infection, care, and identity on care entry. AIDS Care (2011) 0.98
Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med (2013) 0.97
Support, stigma, health, coping, and quality of life in older gay men with HIV. J Assoc Nurses AIDS Care (2012) 0.97
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS (2008) 0.97
Late diagnosis, delayed presentation and late presentation in HIV: proposed definitions, methodological considerations and health implications. Antivir Ther (2013) 0.97
Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol (2014) 0.96
Medication-related barriers to entering HIV care. AIDS Patient Care STDS (2012) 0.96
Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study. AIDS Patient Care STDS (2009) 0.95
Use of the serologic testing algorithm for recent HIV seroconversion (STARHS) to identify recently acquired HIV infections in men with early syphilis in Los Angeles County. J Acquir Immune Defic Syndr (2005) 0.95
Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care. Clin Infect Dis (2010) 0.94